Identifying Patients at Risk for Life-threatening Adverse Effect of Chemotherapy
A new genetic biomarker identified breast cancer patients at increased risk for heart damage caused by anthracycline chemotherapy. Women...
Progress Against Cancer
A new genetic biomarker identified breast cancer patients at increased risk for heart damage caused by anthracycline chemotherapy. Women...
Researchers are using genetic tests to help identify breast cancer patients at risk for potentially life-threatening complications of chemotherapy....
A recent study reports that how pediatricians talk to parents can affect whether or not they chose to have...
Each of the three obesity-related factors, body mass index (BMI), waist size, and type 2 diabetes, was robustly associated...
An investigational immunotherapeutic was safe, tolerable, and showed some activity against melanoma in a phase I clinical trial The...
The number of Hispanic breast cancer patients getting care and participating in a clinical trial in a cancer center...
The lack of androgen receptor protein may contribute to racial disparities in survival for women with this aggressive form...
In an early-phase trial, investigators study whether combining immunotherapies expands “tumor-specific immune activation.” A small phase Ib study of...
Researchers are seeking to understand why some patients do not respond to immunotherapeutics and to identify ways to ensure...
Study: Black patients in highly segregated neighborhoods were less likely to have lung cancer surgery. Despite significant progress in...